Hanseatic Management Services Inc Abb Vie Inc. Transaction History

Hanseatic Management Services Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $551,831 - $635,516	3,816 New	3,816 $619,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $14,450 - $18,370	105 Added 2.75%	3,921 $601,000
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $503,635 - $624,870	3,816 New	3,816 $619,000
Q4 2020 Jan 29, 2021	SELL	$80.49 - $108.67 $71,153 - $96,064	-884 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $75,944 - $89,133	884 New	884 $77,000
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $726,320 - $859,400	-8,090 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$92.01 - $123.21 $110,227 - $147,605	1,198 Added 17.38%	8,090 $766,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $564,228 - $618,723	6,300 Added 1064.19%	6,892 $667,000
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $41,351 - $52,818	592	592 $53,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.